Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
NCT ID: NCT01444456
Last Updated: 2017-03-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1262 participants
OBSERVATIONAL
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Quality of Life will be assessed electronically with the aim of estimating improvement in quality of life for those patients receiving darbepoetin alfa (Aranesp®) who also have an increase in haemoglobin (Hb) of ≥1 g/dL
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy
NCT00283465
Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.
NCT00148421
The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy
NCT00270166
Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy
NCT00003341
Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy
NCT00270127
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort 1: Darbepoetin alfa
Participants receiving systemic chemotherapy for solid tumors who also received darbepoetin alfa (Aranesp®) to treat symptomatic anemia according to routine institutional practice.
No interventions assigned to this group
Cohort 2: Any ESA
Participants receiving systemic chemotherapy for solid tumors who also received darbepoetin alfa (Aranesp®) or another erythropoiesis-stimulating agent (ESA) to treat symptomatic anemia according to routine institutional practice.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Expected to receive at least 8 additional weeks of a given regimen of myelosuppressive chemotherapy after enrolment
* Starting treatment with either darbepoetin alfa (in Cohort 1 countries) or any ESA (in Cohort 2 countries) as per European Summary of Product Characteristics (SPC) for symptomatic anaemia.
Exclusion Criteria
* Known primary benign or malignant haematologic disorder which can cause anaemia
* Known hypersensitivity to ESAs
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amgen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MD
Role: STUDY_DIRECTOR
Amgen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Saint-Quentin, , France
Research Site
Soissons, , France
Research Site
Soyaux, , France
Research Site
Strasbourg, , France
Research Site
Vichy, , France
Research Site
Villefranche-sur-Saône, , France
Research Site
Villejuif, , France
Research Site
Augsburg, , Germany
Research Site
Berlin, , Germany
Research Site
Berlin, , Germany
Research Site
Berlin, , Germany
Research Site
Bremerhaven, , Germany
Research Site
Cologne, , Germany
Research Site
Gelsenkirchen, , Germany
Research Site
Goslar, , Germany
Research Site
Halle, , Germany
Research Site
Mannheim, , Germany
Research Site
Neunkirchen, , Germany
Research Site
Rotenburg (Wümme), , Germany
Research Site
Soest, , Germany
Research Site
Stralsund, , Germany
Research Site
Würselen, , Germany
Research Site
Athens, , Greece
Research Site
Athens, , Greece
Research Site
Chania, , Greece
Research Site
Marousi, , Greece
Research Site
Papagou, , Greece
Research Site
Cefalù PA, , Italy
Research Site
Napoli, , Italy
Research Site
Padua, , Italy
Research Site
Roma, , Italy
Research Site
Enschede, , Netherlands
Research Site
Flushing, , Netherlands
Research Site
Leiderdorp, , Netherlands
Research Site
Purmerend, , Netherlands
Research Site
Roosendaal, , Netherlands
Research Site
Zutphen, , Netherlands
Research Site
Bialystok, , Poland
Research Site
Gdansk, , Poland
Research Site
Konin, , Poland
Research Site
Koszalin, , Poland
Research Site
Krakow, , Poland
Research Site
Lubin, , Poland
Research Site
Olsztyn, , Poland
Research Site
Poznan, , Poland
Research Site
Warsaw, , Poland
Research Site
Wałbrzych, , Poland
Research Site
Wroclaw, , Poland
Research Site
Torino, , Italy
Research Site
Amstelveen, , Netherlands
Research Site
Dordrecht, , Netherlands
Research Site
Graz, , Austria
Research Site
Innsbruck, , Austria
Research Site
Sankt Pölten, , Austria
Research Site
Vienna, , Austria
Research Site
Vöcklabruck, , Austria
Research Site
Wels, , Austria
Research Site
Aalst, , Belgium
Research Site
Bonheiden, , Belgium
Research Site
Brasschaat, , Belgium
Research Site
Bruges, , Belgium
Research Site
Eupen, , Belgium
Research Site
Gilly, , Belgium
Research Site
Mechelen, , Belgium
Research Site
Namur, , Belgium
Research Site
Ostend, , Belgium
Research Site
Sint-Niklaas, , Belgium
Research Site
Verviers, , Belgium
Research Site
Aix-en-Provence, , France
Research Site
Aix-en-Provence, , France
Research Site
Amiens, , France
Research Site
Aubagne, , France
Research Site
Bayonne, , France
Research Site
Besançon, , France
Research Site
Bordeaux, , France
Research Site
Boulogne Sur Mer Cédex, , France
Research Site
Bourg-en-Bresse, , France
Research Site
Brive-la-Gaillarde, , France
Research Site
Carcassonne, , France
Research Site
Clermont-Ferrand, , France
Research Site
Clermont-Ferrand, , France
Research Site
Colmar, , France
Research Site
Dijon, , France
Research Site
Draguignan, , France
Research Site
La Seyne-sur-Mer, , France
Research Site
Le Mans, , France
Research Site
Longjumeau, , France
Research Site
Marseille, , France
Research Site
Marseille, , France
Research Site
Mont-de-Marsan, , France
Research Site
Montauban, , France
Research Site
Nancy, , France
Research Site
Orléans, , France
Research Site
Paris, , France
Research Site
Périgueux, , France
Research Site
Pontoise, , France
Research Site
Pringy, , France
Research Site
Reims, , France
Research Site
Reims, , France
Research Site
Reims, , France
Research Site
Rennes, , France
Research Site
Rouen, , France
Research Site
Saint-Grégoire, , France
Research Site
Wroclaw, , Poland
Research Site
Alba Iulia, , Romania
Research Site
Baia Mare, , Romania
Research Site
Brasov, , Romania
Research Site
Bucharest, , Romania
Research Site
Bucharest, , Romania
Research Site
Bucharest, , Romania
Research Site
Bucharest, , Romania
Research Site
Bucharest, , Romania
Research Site
Cluj-Napoca, , Romania
Research Site
Oradea, , Romania
Research Site
Râmnicu Vâlcea, , Romania
Research Site
Târgu Mureş, , Romania
Research Site
Timișoara, , Romania
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mouysset JL, Freier B, van den Bosch J, Levache CB, Bols A, Tessen HW, Belton L, Bohac GC, Terwey JH, Tonini G. Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study. Cancer Manag Res. 2016 Jan 21;8:1-10. doi: 10.2147/CMAR.S88110. eCollection 2016.
Related Links
Access external resources that provide additional context or updates about the study.
AmgenTrials clinical trials website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20101123
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.